ArticleClinicoEconomics and outcomes research : CEOR2026

Cost-Effectiveness and Clinical Utility of Pancreatic Cancer Non-Invasive Test in New-Onset Diabetes.

Adrian Vilalta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.